Positive Results From A Phase IIa Study Of S-2367, A Novel Neuropeptide Y5 Receptor Antagonist For The Treatment Of Obesity
Shionogi & Co, Ltd. today announced positive top-line efficacy results from a Phase IIa proof-of-concept trial with S-2367, an internally discovered drug candidate for obesity and related conditions. The unique mechanism of action of S-2367 involves blocking receptor binding of neuropeptide Y (NPY), a neurotransmitter involved in regulation of energy balance and food consumption. [click link for full article]

Online Weight Loss Tools Quickly Becoming Preferred Solution For Americans Today
More and more Americans are usingthe Internet for everything from buying a new car to paying bills andbooking vacations. Approximately 77% of Americans are now online, up from74% in 2005, and compared with 57% back in 2000.(1) Now, Americans are evendieting online -- seeking the tools, support and motivation of onlinecommunities to achieve weight loss goals. [click link for full article]

Get Slim With A Little Help From Your Friend
Reaching for that gallon of icecream? Reach for your computer mouse instead and do what many successfuldieters do to stick to their diet plan: buddy up to slim down. Clinical studies show getting social support by "Buddying Up" increasesweight loss success by encouraging dieters to stick to their diet andlifestyle improvement plans. More and more dieters are finding their BuddySupport network online at newly launched BuddySlim. [click link for full article]

Facts On Diet And Nutrition: GreenFacts Publishes Its 25th Study
How can improved eating habits and increased physical activity help reduce the risk of chronic diseases? This is the subject of GreenFacts' 25th Study, Diet and Nutrition, which is now published on www.greenfacts.org/en/diet-nutrition/. The Study is a summary of a joint WHO/FAO (World Health Organization/Food and Agriculture Organization of the United Nations) expert consultation titled "Diet, Nutrition and the Prevention of Chronic Diseases". [click link for full article]

Fat Rapid Loss Capsules (Xin Yan Zi Pai Mei Zi Jiao Nang), Canada
Health Canada is advising consumers not to use the following products listed in the table below due to concerns about possible side effects. These products are not authorized for sale in Canada and have not been found in the Canadian marketplace. However, it is possible these products could be purchased by Canadians travelling abroad or have been brought into Canada through personal importation by travellers or purchased over the Internet. [click link for full article]

Weight Watchers Announces Second Quarter 2006 Earnings Conference Call
Weight WatchersInternational Inc. (NYSE: WTW) will release its results for the secondquarter 2006 after the NYSE close on Tuesday, August 1, 2006. The Company has also scheduled a conference call on August 1st at 5:00p.m. ET. During the conference call, Linda Huett, President and ChiefExecutive Officer, and Ann Sardini, Chief Financial Officer, will discusssecond quarter results and answer questions from the investment community. [click link for full article]

Diabetes Type 2 Ages You By 15 Years
If you develop diabetes type 2 you are likely to suffer from heart attacks, strokes and other cardiovascular problems 15 years earlier than somebody who does not have diabetes type 2, according to scientists from the Institute of Clinical Evaluative Sciences, Toronto, Canada. You can read about this study in the journal The Lancet.According to Dr. [click link for full article]

Obesity Concerns Change Focus Of America's $61 Billion Addiction To Munchies
While Americans feeding theiraddiction to munchies shelled out $61.4 billion for snack foods in 2005, agreater portion of their cash outlay went to healthier products, accordingto Snack Food Trends in the U.S., a new report from Packaged Facts. [click link for full article]

Shionogi Announces Positive Results From A Phase IIa Study Of S-2367, A Novel Neuropeptide Y5 Receptor Antagonist For The Treatment Of Obesity
Shionogi & Co, Ltd. today announced positive top-line efficacy results froma Phase IIa proof-of-concept trial with S-2367, an internally discovereddrug candidate for obesity and related conditions. The unique mechanism ofaction of S-2367 involves blocking receptor binding of neuropeptide Y(NPY), a neurotransmitter involved in regulation of energy balance and foodconsumption. [click link for full article]

Breast Cancer Risk Increased With Weight Gain In Postmenopausal Women
Weight gain, particularly after menopause, is associated with an increased risk of breast cancer in women, according to an article in the July 12 issue of JAMA.Background information in the article indicates that weight loss after menopause lowers circulating estrogen hormones in women, and because estrogen is directly related to breast cancer, weight loss is thought to decrease risk of the disease. [click link for full article]

Eating Habits Of Successful Weight Losers Shift
A recent study suggests that the fat intake of successful weight losers entering the National Weight Control Registry has increased over the past decade, while carbohydrate intake has declined. This is the finding of a research paper appearing in the April 2006 issue of Obesity Research by researchers at The Miriam Hospital and Brown Medical School, and University of Colorado. [click link for full article]